Quest Diagnostics
$233.33Change from previous close: +0.97%Absolute change: +$2.24
At a glance
- Revenue growth
- +11.78%
- 2025 vs 2024
- Net income growth
- +13.89%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 8.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 597 | 278 | 465 | 563 | 544 | — |
| Depreciation and amortization | 146 | 147 | 145 | 142 | 143 | — |
| Capital expenditure | -138 | -114 | -158 | -144 | -108 | — |
| Investing cash flow | -134 | -152 | -191 | -201 | -124 | — |
| Financing cash flow | -229 | -152 | -287 | -247 | -293 | — |
| Dividends paid | -96.0 | -88.0 | -90.0 | -89.0 | -90.0 | — |
| Share repurchases | — | — | -300 | -150 | — | — |
| Debt issued | 494 | 0.0 | 0.0 | 10.0 | 185 | — |
| Debt repaid | -500 | -1.0 | -1.0 | -10.0 | -401 | — |
| Effect of exchange rates | -1.0 | -1.0 | 1.0 | -2.0 | 4.0 | — |
| Net change in cash | 234 | -26.0 | -13.0 | 115 | 127 | — |
| Free cash flow | 459 | 164 | 307 | 419 | 436 | — |